Navigation Links
Sono-Tek Announces its Largest Ever Sales of MediCoat Stent Coating Systems to a Leading Global Medical Device Manufacturer
Date:9/15/2009

MILTON, N.Y., Sept. 15 /PRNewswire-FirstCall/ -- Sono-Tek Corporation (OTC Bulletin Board: SOTK) announced today the sale of a series of its MediCoat DES 2000 stent coating systems to a leading global medical device manufacturer. The sale is Sono-Tek's largest ever sales transaction to the medical device industry, valued at approximately $400,000.

The confidential global client has already owned Sono-Tek systems for a number of years, and operated them successfully in the manufacture of high quality cardiac stents. The MediCoat DES 2000 incorporates Sono-Tek's proven MicroMist ultrasonic atomizing nozzle, and provides stent motion that assures a complete, uniform and accurate micronic layer coating, in a validated process.

Dr. Joseph Riemer, Sono-Tek president stated, "Capital investments in the medical device manufacture industry are undergoing strict financial due diligence and comprehensive operational performance evaluations in the current economic climate. This large repeat order is a vote of confidence for Sono-Tek's ultrasonic atomization technology in general, and for our MediCoat DES 2000 in particular."

Sono-Tek Chairman and CEO, Dr. Christopher L. Coccio added, "Sono-Tek's strategy is to design, build and sell superior coating equipment which provides our customers with the highest quality products at significantly reduced operational costs. These advantages and benefits are unmatched by any conventional spraying system vendor. During the course of the last few quarters, we focused this strategy successfully on specific industries which are less impacted by the global economic downturn. Our recent successes in the medical device, food and advanced energy sectors, enabled Sono-Tek to show growth in a difficult economic environment, and provide guidance regarding expected growth at our recent Annual Shareholders Meeting which was held in August 2009."

For further information, contact Dr. Christopher L. Coccio, at 845-795-2020, or visit our website at www.sono-tek.com.

Sono-Tek Corporation is a leading developer and manufacturer of liquid spray products based on its proprietary ultrasonic nozzle technology. Founded in 1975, the Company's products have long been recognized for their performance, quality, and reliability.

This release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, competitive and technological developments affecting the Company's operations or the demand for its products; timely development and market acceptance of new products; adequacy of financing; capacity additions, restoration of profitability and the ability to enforce patents. We refer you to documents that the company files with the Securities and Exchange Commission, which includes Form 10-K and Form 10-Qs containing additional important information.


'/>"/>
SOURCE Sono-Tek Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sono-Tek Announces First Quarter Results
2. Nuvilex, Inc. Announces That Reme-Flu(TM) Will Be Available For Sale On Top-Rated Internet Website
3. Global Med Technologies(R), Inc. Announces Its First EdgeCell Cellular Therapy Software and EdgeLab/HLA Software Sale in North America
4. Accumetrics, Inc. Announces Endotech SPA as Exclusive Distributor for the VerifyNow System in Italy
5. Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of F. Folsom Bell to Board of Directors
6. Advanced Life Sciences Announces Restanza(TM) Granted FDA Orphan Drug Designation for Plague and Tularemia
7. Accuray Announces Additions to Board of Directors
8. Palatin Technologies, Inc. Announces PL-3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting
9. BioCryst Announces Partnerships for Peramivir for Influenza Outside the U.S.
10. avVaa World Health Care Products, Inc. Announces DRTV Test Results
11. Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are ... help with process innovation in drug formulation and manufacturing. CoreRx offers its ... analytical equipment in support of their development and manufacturing goals. , The ...
(Date:4/25/2017)... ... ... Back Pain Centers of America (BPC), which connects people searching for ... announces the launch of a new and proprietary customer relationship management (CRM) system named ... to help them with back or neck pain and helps to match them with ...
(Date:4/25/2017)... ... , ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine care ... on preventative care with all my patients to alleviate possible future issues. I am pleased ... contact my office and my trained staff will assist you in any way possible.” , ...
(Date:4/25/2017)... ... 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow ... Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, ... College of Medicine. He also serves as Medical Director for the Bureau of Emergency ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... for large animal healthcare products, is introducing Flexadin UCII, part of the EQUISTRO ... cartilage development and joint health in horses at the immunologic level. , The ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
(Date:4/19/2017)... , April 19, 2017 ... an immune response in pets such as canine, ... are of various types such as Attenuated Live ... Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated live ... virus or bacteria, which have been weakend under ...
(Date:4/19/2017)... EAST HANOVER, N.J. , April 19, 2017 ... study conducted by the National Heart, Lung, and ... Health (NIH) demonstrating that 58% of patients with ... at six months when treated with eltrombopag at ... treatment 1 . The study evaluated three sequential ...
Breaking Medicine Technology: